相关实验视频
Updated: Jun 5, 2025
07:44
A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
295
对急性中高风险和高风险肺栓塞的干预治疗的研究进展
1Department of Vascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Journal of thoracic disease
|December 16, 2024
概括
急性肺栓塞 (APE) 治疗正在发展,血管内干预对高风险患者有希望. 这些先进疗法旨在改善结局并降低肺栓塞 (PE) 的死亡率.
科学领域:
- 心脏病学 心脏病学
- 干预性放射学 干预性放射学
- 肺部医学 肺部医学
背景情况:
- 急性肺栓塞 (APE) 是全球主要的死亡原因,主要是由于右心力衰竭.
- 目前的治疗指南建议高风险PE进行血栓溶解疗法,但临床应用受到出血风险的限制.
- 对于中等风险PE患者的最佳治疗策略尚不清楚.
研究的目的:
- 审查目前对中等高风险和高风险PE的内血管干预治疗方法.
- 提供PE干预治疗研究进展的最新情况.
- 讨论与APE和干预治疗相关的风险分层和长期结果.
主要方法:
- 对内血管干预治疗的审查,包括标准导管血栓溶解 (SCDT),超声辅助血栓溶解 (USAT),药理导管导管血栓溶解 (PM-CDT) 和机械血栓切除术 (MT).
- 分析APE风险分层的最新指南,包括风险指标和预后得分.
- 讨论关于PE干预疗法的有效性和安全性的现有研究.
主要成果:
- 血管内干预疗法在改善PE患者右心功能方面表现出有效性.
- 这些治疗方法显示,与传统方法相比,脑出血的发生率有所降低.
- 需要进一步的研究来确定从干预治疗中受益最多的特定患者群体.
结论:
- 干预疗法在管理高风险PE方面取得了重大进展,为全身血栓溶解提供了替代方案.
- 风险分层和仔细的患者选择对于优化APE结果至关重要.
- 专注于患者选择,死亡率降低和长期后果的持续研究对于推进PE护理至关重要.
相关概念视频
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
147
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
147
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
135
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
135